| Dr Mayur Khandu Patel, MD | |
|
1234 Huffman Mill Road, Burlington, NC 27215-8700 | |
| (336) 538-1234 | |
| (336) 584-6811 |
| Full Name | Dr Mayur Khandu Patel |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 16 Years |
| Location | 1234 Huffman Mill Road, Burlington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386802205 | NPI | - | NPPES |
| P01267998 | Other | SC | RAILROAD MEDICARE |
| 356386 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 35638 (South Carolina) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 2013-00683 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.
Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.
B. Braun Melsungen AG, the global leader in regional anesthesia and pain management, and Royal Philips, a global leader in ultrasound and image guided therapy solutions, today announced a multi-year strategic alliance to innovate ultrasound-guided regional anesthesia – a rapidly growing alternative to general anesthesia – and vascular access.
Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.
› Verified 4 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.
Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.
B. Braun Melsungen AG, the global leader in regional anesthesia and pain management, and Royal Philips, a global leader in ultrasound and image guided therapy solutions, today announced a multi-year strategic alliance to innovate ultrasound-guided regional anesthesia – a rapidly growing alternative to general anesthesia – and vascular access.
Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.
› Verified 4 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.
Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.
B. Braun Melsungen AG, the global leader in regional anesthesia and pain management, and Royal Philips, a global leader in ultrasound and image guided therapy solutions, today announced a multi-year strategic alliance to innovate ultrasound-guided regional anesthesia – a rapidly growing alternative to general anesthesia – and vascular access.
Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mayur Khandu Patel, MD 1234 Huffman Mill Road, Burlington, NC 27215-8700 Ph: (336) 538-1234 | Dr Mayur Khandu Patel, MD 1234 Huffman Mill Road, Burlington, NC 27215-8700 Ph: (336) 538-1234 |
News Archive
HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.
Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.
B. Braun Melsungen AG, the global leader in regional anesthesia and pain management, and Royal Philips, a global leader in ultrasound and image guided therapy solutions, today announced a multi-year strategic alliance to innovate ultrasound-guided regional anesthesia – a rapidly growing alternative to general anesthesia – and vascular access.
Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.
› Verified 4 days ago
Dr. Ayesha Ali, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 729 Meadowood Dr, Burlington, NC 27215 Phone: 347-606-0485 | |
Mr. Dwayne Dennis Callwood, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1234 Huffman Mill Road, Burlington, NC 27215 Phone: 336-538-2374 Fax: 336-584-6811 | |
Dr. Fozia Muhstaqe Khan, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2991 Crouse Ln, Burlington, NC 27215 Phone: 336-586-0994 Fax: 336-586-9363 | |
Dr. Muhammad Arida, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1236 Huffman Mill Rd Ste 130, Burlington, NC 27215 Phone: 336-438-1060 | |
Janak Kantilal Choksi, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1236 Huffman Mill Rd, Suite #120, Burlington, NC 27215 Phone: 336-538-7725 Fax: 336-538-7785 | |
Dr. Anna Melissa Solum, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1234 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-1234 Fax: 336-538-2390 | |
Dr. Munsoor Lateef, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2903 Professional Park Dr, Suite D, Burlington, NC 27215 Phone: 336-584-4913 Fax: 336-584-4914 |